rs779832256

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_003122.5(SPINK1):​c.-147A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000632 in 1,513,248 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00074 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 6 hom. )

Consequence

SPINK1
NM_003122.5 5_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2O:1

Conservation

PhyloP100: 3.28
Variant links:
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000742 (113/152332) while in subpopulation NFE AF= 0.000309 (21/68036). AF 95% confidence interval is 0.000207. There are 2 homozygotes in gnomad4. There are 47 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 113 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK1NM_001354966.2 linkc.-147A>G 5_prime_UTR_variant Exon 2 of 5 NP_001341895.1
SPINK1NM_003122.5 linkc.-147A>G 5_prime_UTR_variant Exon 2 of 5 NP_003113.2 P00995
SPINK1XM_047417625.1 linkc.-147A>G 5_prime_UTR_variant Exon 3 of 6 XP_047273581.1
SPINK1XM_047417626.1 linkc.-147A>G 5_prime_UTR_variant Exon 3 of 6 XP_047273582.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152214
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000955
GnomAD4 exome
AF:
0.000619
AC:
843
AN:
1360916
Hom.:
6
Cov.:
30
AF XY:
0.000666
AC XY:
446
AN XY:
670008
show subpopulations
Gnomad4 AFR exome
AF:
0.000195
Gnomad4 AMR exome
AF:
0.000472
Gnomad4 ASJ exome
AF:
0.0214
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000196
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000165
Gnomad4 OTH exome
AF:
0.00159
GnomAD4 genome
AF:
0.000742
AC:
113
AN:
152332
Hom.:
2
Cov.:
33
AF XY:
0.000631
AC XY:
47
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.0216
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.000763
Hom.:
0
Bravo
AF:
0.000733
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityJul 08, 2022- -
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 26, 2024The SPINK1 c.-147A>G variant (rs779832256) is reported in the literature in individuals affected with pancreatitis or pancreatic cancer, but is also found in healthy controls (Boulling 2011, Derikx 2015, Keiles 2006, Slavin 2018). This variant is also reported in ClinVar (Variation ID: 239503), and is found in the general population with an overall allele frequency of 0.022% (7/31408 alleles) in the Genome Aggregation Database (v2.1.1). This variant occurs in the 5' untranslated region at a nucleotide that is weakly conserved, and in vitro reporter assays demonstrate reduced expression (Boulling 2011, Derikx 2015). However, whether reduced expression occurs in vivo or is sufficient for disease remains to be determined. Given available information, the clinical significance of this variant is uncertain at this time. References: Boulling A et al. Assessing the pathological relevance of SPINK1 promoter variants. Eur J Hum Genet. 2011 Oct;19(10):1066-73. PMID: 21610753. Derikx MH et al. Functional significance of SPINK1 promoter variants in chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2015 May 1;308(9):G779-84. PMID: 25792561. Keiles S et al. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas. 2006 Oct;33(3):221-7. PMID: 17003641. Slavin TP et al. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Fam Cancer. 2018 Apr;17(2):235-245. PMID: 28687971. -
Hereditary pancreatitis Uncertain:2Other:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 25, 2021The c.-147A>G variant is located in the 5' untranslated region (5’ UTR) of the SPINK1 gene. This variant results from an A to G substitution 147 bases upstream from the first translated codon. This nucleotide position is highly conserved in available vertebrate species. The variant has been detected in multiple individuals with pancreatitis or pancreatic cancer (Keiles S et al. Pancreas, 2006 Oct;33:221-7; Boulling A et al. Eur. J. Hum. Genet., 2011 Oct;19:1066-73; Slavin TP et al. Fam Cancer, 2018 04;17:235-245). Functional studies showed that this alteration disrupts a putative HNF1-binding site and reduces the SPINK1 promoter activity (Boulling A et al. Eur. J. Hum. Genet., 2011 Oct;19:1066-73; Derikx MH et al. Am. J. Physiol. Gastrointest. Liver Physiol., 2015 May;308:G779-84). However, it is unknown whether the reduced promoter activity is sufficient to cause disease. In addition, the variant has been detected in multiple unaffected individuals at our laboratory. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided, no classification providedphenotyping onlyGenomeConnect - Invitae Patient Insights Network-Variant interpreted as Uncertain significance and reported on 11-30-2018 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 08, 2024This variant occurs in a non-coding region of the SPINK1 gene. It does not change the encoded amino acid sequence of the SPINK1 protein. This variant is present in population databases (rs779832256, gnomAD 1.7%), and has an allele count higher than expected for a pathogenic variant. This variant has been observed in individual(s) with chronic pancreatitis or pancreatic cancer (PMID: 17003641, 21610753, 28687971). ClinVar contains an entry for this variant (Variation ID: 239503). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects SPINK1 function (PMID: 21610753, 25792561, 28556356). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Tropical pancreatitis Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsSep 28, 2023- -
Hereditary pancreatitis;C1842402:Tropical pancreatitis Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsFeb 18, 2024- -
SPINK1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesFeb 17, 2022This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
17
DANN
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs779832256; hg19: chr5-147211287; API